Leaflet VISANNE 2mg tablets

Indicated for: endometriosis; uterine fibroids

Route of administration: oral

Substance: dienogest (progestogen)

ATC: G03DB08 (Genito urinary system and sex hormones | Progestogens | Pregnadien derivatives)

Precautions:
Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Dienogest is a progestin primarily used to treat endometriosis, a condition in which endometrial tissue grows outside the uterus, causing pain and other symptoms. It works by reducing estrogen production and inhibiting the growth of endometrial tissue.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include headaches, nausea, weight changes, or irregular menstrual bleeding. In rare cases, more severe adverse effects such as depression or blood clots may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about VISANNE 2mg

  • Substance: dienogest
  • Date of latest medicines list: 01-06-2026
  • Product code: W64053001
  • Concentration: 2mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: Original
  • Price: 133.81 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: BAYER WEIMAR GMBH und CO.KG - GERMANIA
  • Holder: BAYER AG - GERMANIA
  • Number: 7329/2015/01
  • Shelf life: 5 years